{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T20:03:58Z","timestamp":1789848238462,"version":"4.0.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgery"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.surg.2026.110402","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T23:18:46Z","timestamp":1781911126000},"page":"110402","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Use of mesoglycan in the acute phase of hemorrhoidal disease, the aCute HaemORrhoidal MEsoglycan Study (CHORMES): A double-blind, randomized controlled trial"],"prefix":"10.1016","volume":"198","author":[{"given":"Gaetano","family":"Gallo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Salvatore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Tomasicchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Realis Luc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6361-1111","authenticated-orcid":false,"given":"Arcangelo","family":"Picciariello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Di Vittori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Trompetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcella","family":"Rinaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.surg.2026.110402_bib1","series-title":"Hemorrhoids [Internet]","first-page":"3","article-title":"Epidemiology of hemorrhoidal disease","author":"Gallo","year":"2018"},{"key":"10.1016\/j.surg.2026.110402_bib2","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.2217\/cer-2020-0159","article-title":"The prevalence, characteristics and treatment of hemorrhoidal disease: results of an international web-based survey","volume":"9","author":"Sheikh","year":"2020","journal-title":"J Comp Effec Res"},{"key":"10.1016\/j.surg.2026.110402_bib3","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.sopen.2023.02.004","article-title":"Quality of life in patients with hemorrhoidal disease","volume":"12","author":"R\u00f8rvik","year":"2023","journal-title":"Surg Open Sci"},{"key":"10.1016\/j.surg.2026.110402_bib4","doi-asserted-by":"crossref","first-page":"798","DOI":"10.14309\/ajg.0000000000000143","article-title":"Burden and cost of outpatient hemorrhoids in the United States employer-insured population, 2014","volume":"114","author":"Yang","year":"2019","journal-title":"J Am Gastroenterol"},{"key":"10.1016\/j.surg.2026.110402_bib5","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1056\/NEJMcp1204188","volume":"371","author":"Hemorrhoids","year":"2014","journal-title":"New Engl J Med"},{"key":"10.1016\/j.surg.2026.110402_bib6","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.3748\/wjg.v18.i17.2009","article-title":"Hemorrhoids: from basic pathophysiology to clinical management","volume":"18","author":"Lohsiriwat","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.surg.2026.110402_bib7","first-page":"10","article-title":"Classifications and clinical assessment of haemorrhoids: the proctologist\u2019s corner","volume":"16","author":"Picciariello","year":"2021","journal-title":"Rev Recent Clin Trials"},{"key":"10.1016\/j.surg.2026.110402_bib8","author":"Goligher"},{"key":"10.1016\/j.surg.2026.110402_bib9","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s10151-022-02591-3","article-title":"Is the Goligher classification a valid tool in clinical practice and research for hemorrhoidal disease?","volume":"26","author":"Dekker","year":"2022","journal-title":"Tech Coloproctol"},{"key":"10.1016\/j.surg.2026.110402_bib10","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10151-025-03170-y","article-title":"Limitations of the Goligher classification in randomized trials for hemorrhoidal disease: a qualitative systematic review of selection criteria","volume":"29","author":"Van Oostendorp","year":"2025","journal-title":"Tech Coloproctol"},{"key":"10.1016\/j.surg.2026.110402_bib11","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/DCR.0000000000001234","article-title":"Hemorrhoidal disease symptom score and short health ScaleHD: new tools to evaluate symptoms and health-related quality of life in hemorrhoidal disease","volume":"62","author":"R\u00f8rvik","year":"2019","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.surg.2026.110402_bib12","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/gut.44.1.77","article-title":"Prospective comparison of faecal incontinence grading systems","volume":"44","author":"Vaizey","year":"1999","journal-title":"Gut"},{"key":"10.1016\/j.surg.2026.110402_bib13","article-title":"Time to change? Present and prospects of hemorrhoidal classification","volume":"10","author":"Wang","year":"2023","journal-title":"Front Med"},{"key":"10.1016\/j.surg.2026.110402_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fsurg.2022.898850","article-title":"Management and treatment of external hemorrhoidal thrombosis","volume":"9","author":"Picciariello","year":"2022","journal-title":"Front Surg"},{"key":"10.1016\/j.surg.2026.110402_bib15","doi-asserted-by":"crossref","first-page":"232","DOI":"10.2174\/1574887114666190927163646","article-title":"Thrombosed external haemorrhoids: a clinician\u2019s dilemma","volume":"14","author":"Sammarco","year":"2019","journal-title":"Rev Recent Clin Trials"},{"key":"10.1016\/j.surg.2026.110402_bib16","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10151-020-02149-1","article-title":"Consensus statement of the Italian society of colorectal surgery (SICCR): management and treatment of hemorrhoidal disease","volume":"24","author":"Gallo","year":"2020","journal-title":"Tech Coloproctol"},{"key":"10.1016\/j.surg.2026.110402_bib17","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/6423895","article-title":"Efficacy of mesoglycan in pain control after excisional hemorrhoidectomy: a pilot comparative prospective multicenter study","volume":"2018","author":"Gallo","year":"2018","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.surg.2026.110402_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2021.680836","article-title":"Glycosaminoglycans: from vascular physiology to tissue engineering applications","volume":"9","author":"Lepedda","year":"2021","journal-title":"Front Chem"},{"key":"10.1016\/j.surg.2026.110402_bib19","article-title":"Mesoglycan: clinical evidences for use in vascular diseases","volume":"2010","author":"Tufano","year":"2010","journal-title":"Int J Vasc Med"},{"key":"10.1016\/j.surg.2026.110402_bib20","first-page":"168","article-title":"Effects of prisma skin dermal regeneration device containing glycosaminoglycans on human keratinocytes and fibroblasts","volume":"12","author":"Belvedere","year":"2018","journal-title":"Cell Adhes Migration"},{"key":"10.1016\/j.surg.2026.110402_bib21","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s13304-024-01776-9","article-title":"Clinical evidence and rationale of mesoglycan to treat chronic venous disease and hemorrhoidal disease: a narrative review","volume":"76","author":"Gallo","year":"2024","journal-title":"Updates Surg"},{"key":"10.1016\/j.surg.2026.110402_bib22","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s12893-020-00914-5","article-title":"Mesoglycan for pain control after open excisional HAEMOrrhoidectomy (MeHAEMO): an observational multicentre study on behalf of the Italian Society of Colorectal Surgery (SICCR)","volume":"20","author":"Gallo","year":"2020","journal-title":"BMC Surg"},{"key":"10.1016\/j.surg.2026.110402_bib23","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s10151-023-02889-w","article-title":"Postoperative pain after haemorrhoidal disease treatment: a still unsolved problem","volume":"28","author":"Gallo","year":"2023","journal-title":"Tech Coloproctol"},{"key":"10.1016\/j.surg.2026.110402_bib24","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.3390\/ijms26094046","article-title":"Local and systemic endothelial damage in patients with CEAP C2 chronic venous insufficiency: role of Mesoglycan","volume":"26","author":"Santoliquido","year":"2025","journal-title":"IJMS"},{"key":"10.1016\/j.surg.2026.110402_bib25","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1186\/s13063-024-08648-y","article-title":"Use of mesoglycan in the acute phase of hemorrhoidal disease (the CHORMES study): study protocol for a double-blind, randomized controlled trial","volume":"25","author":"Gallo","year":"2024","journal-title":"Trials"},{"key":"10.1016\/j.surg.2026.110402_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/6423895","article-title":"Efficacy of Mesoglycan in pain control after excisional hemorrhoidectomy: a pilot comparative prospective multicenter study","volume":"2018","author":"Gallo","year":"2018","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.surg.2026.110402_bib27","first-page":"1909","article-title":"[Mesoglycan sulfate in acute hemorrhoidal pathology]","volume":"77","author":"Saggioro","year":"1986","journal-title":"Minerva Med"},{"key":"10.1016\/j.surg.2026.110402_bib28","first-page":"311","article-title":"[Treatment of hemorrhoidal crisis with mesoglycan sulfate]","volume":"31","author":"Saggioro","year":"1985","journal-title":"Minerva Dietol Gastroenterol"},{"key":"10.1016\/j.surg.2026.110402_bib29","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1007\/s12325-020-01353-7","article-title":"Micronized purified flavonoid fraction in hemorrhoid disease: a systematic review and meta-analysis","volume":"37","author":"Sheikh","year":"2020","journal-title":"Adv Ther"},{"key":"10.1016\/j.surg.2026.110402_bib30","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s10151-015-1302-9","article-title":"Flavonoids mixture (diosmin, troxerutin, hesperidin) in the treatment of acute hemorrhoidal disease: a prospective, randomized, triple-blind, controlled trial","volume":"19","author":"Giannini","year":"2015","journal-title":"Tech Coloproctol"},{"key":"10.1016\/j.surg.2026.110402_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154244","article-title":"Efficacy and safety of micronized purified flavonoid fractions for the treatment of postoperative hemorrhoid complications: a systematic review and meta-analysis","volume":"104","author":"Fu","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.surg.2026.110402_bib32","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1097\/IA9.0000000000000070","article-title":"Multiple target oral therapy with diosmin, extract of Vitis vinifera, Ruscus aculeatus, and Melilotus officinalis for the conservative management of hemorrhoidal disease: preliminary results from the VIVI2022\/01\/VIVALDI study","volume":"45","author":"Giani","year":"2025","journal-title":"Il Giorn Chir"}],"container-title":["Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606026003272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606026003272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T19:26:53Z","timestamp":1789846013000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039606026003272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":32,"alternative-id":["S0039606026003272"],"URL":"https:\/\/doi.org\/10.1016\/j.surg.2026.110402","relation":{},"ISSN":["0039-6060"],"issn-type":[{"value":"0039-6060","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of mesoglycan in the acute phase of hemorrhoidal disease, the aCute HaemORrhoidal MEsoglycan Study (CHORMES): A double-blind, randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.surg.2026.110402","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110402"}}